Äڷγª-19 Áúº´ ½É°¢µµ¿Í °ü·ÃµÈ ±âÁ¸ Ư¼º
- ÀúÀÚJoseph E. Ebinger, Natalie Achamallah, Hongwei Ji, Brian L. Claggett6, Nancy Sun, Patrick
- ÃâÆÇ»ç¾ÆÁø
- ÃâÆÇÀÏ2020-09-18
- µî·ÏÀÏ2020-12-21
- SNS°øÀ¯
- ÆÄÀÏÆ÷¸ËPDF
- ÆÄÀÏÅ©±â11MB
- °ø±Þ»çYES24
-
Áö¿ø±â±â
PC
PHONE
TABLET
ÇÁ·Î±×·¥ ¼öµ¿¼³Ä¡
ÀüÀÚÃ¥ ÇÁ·Î±×·¥ ¼öµ¿¼³Ä¡ ¾È³»
¾ÆÀÌÆù, ¾ÆÀÌÆеå, ¾Èµå·ÎÀ̵åÆù, ÅÂºí¸´,
º¸À¯ 1, ´ëÃâ 0,
¿¹¾à 0, ´©Àû´ëÃâ 6, ´©Àû¿¹¾à 0
Ã¥¼Ò°³
¾î¶² »ç¶÷µéÀº »ç½º-CoV-2¿¡ °¨¿°µÇ¾úÀ» ¶§, ºÒºÐ¸íÇÑ ÀÌÀ¯·Î ´õ ½É°¢ÇÑ ÇüÅÂÀÇ Covid-19 º´¿¡ °É¸®´Â °æÇâÀÌ ÀÖ´Ù. ÀÌ ³í¹®Àº Covid-19 °¨¿°ÀÇ ½É°¢µµ Áõ°¡¿Í °ü·ÃµÈ Àα¸Åë°èÇÐÀû ¹× ÀÓ»óÀû Ư¼º¿¡ ´ëÇÏ¿© ÀÛ¼ºÇÏ¿´´Ù. ¶ÇÇÑ, ȯÀÚ¿¡ ´ëÇÏ¿© ȸ°íÀû °üÂû ¿¬±¸. ÀüÀÚ °Ç° ±â·Ï¿¡¼ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í ´Ùº¯·® ·ÎÁö½ºÆ½ ȸ±Í ºÐ¼®À» »ç¿ëÇÏ¿© ÇÊ¿äÇÑ Ä¡·á ¼öÁØ(º´¿ø ÀÔ¿ø ÇÊ¿ä, ÁýÁß Ä¡·á ÇÊ¿ä, »ð°ü ÇÊ¿ä)¿¡ µû¶ó Á¤ÀÇµÈ Covid-19 Áúº´ ½É°¢µµ¿Í ±âÁ¸ Ư¼ºÀÇ ¿¬°ü¼ºÀ» °Ë»çÇß´Ù.¸ñÂ÷
Á¦ 1Æí Äڷγª¹ÙÀÌ·¯½º Á¤ÀÇ1. Äڷγª¹ÙÀÌ·¯½º°¨¿°Áõ-19(Covid-19) Á¤º¸ 7
2. Äڷγª¹ÙÀÌ·¯½º ºÐ·ù ¹× Ư¼º 9
3. Äڷγª¹ÙÀÌ·¯½º ÀüÀÚÇö¹Ì°æ ÇüÅ 11
4. Äڷγª¹ÙÀÌ·¯½º ±¸Á¶ (Covid-19 Organization) 13
5. Äڷγª19: ȯ°æ¿¡ Áö¼ÓÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥±î? 19
6. Ä¡·á¹ý(Therapeutical Method) 22
Á¦ 2Æí ¿¬±¸³í¹®
Pre-existing traits associated with Covid-19 illness severity
1. Introduction 24
2. Methods 25
3. Statistical analyses 26
4. Results 26
5. Discussion 30
6. References 34